Texas AG Ken Paxton Probes Lululemon for ‘Forever Chemicals’ in Activewear
The Texas attorney general has opened a formal probe into Lululemon USA Inc. The office issued a Civil Investigative Demand to the athletic apparel company.
Reasons for the inquiry
State officials want to know whether Lululemon misled shoppers about product safety. The review will examine claims about quality and health impacts.
The move comes as Texas AG Ken Paxton investigates claims that forever chemicals may be present in activewear. The probe seeks records on testing, supply chains, and marketing.
Areas under review
Investigators will review the company’s restricted substances list. They will also examine in-house testing protocols and third-party test results.
The attorney general’s office plans to scrutinize supply-chain practices. Officials want to determine whether apparel meets the company’s stated safety standards.
Health concerns tied to PFAS
PFAS are synthetic compounds often called “forever chemicals.” Research links them to endocrine disruption, infertility, and some cancers.
- Endocrine system effects
- Potential impacts on fertility
- Possible links to certain cancers
Company response
Lululemon says it no longer uses PFAS. The company says it phased out those substances in fiscal year 2023.
It acknowledged prior use in a small share of durable water-repellent products. Lululemon added that guest safety remains a top priority.
The brand stated it requires vendors to run regular tests for restricted substances. It said vendor tests must be conducted by credible third parties.
Lululemon confirmed cooperation with the attorney general by providing requested documents. The company said its policies, including a Restricted Substances program, are publicly available.
Statements from the attorney general
Ken Paxton emphasized consumer protection as a priority. He said regulators will act if companies violate Texas law.
Current status and next steps
No wrongdoing has been proven. The investigation is ongoing and may lead to further legal action.
Both regulators and the company continue to gather documentation. Consumers and industry watchers will await additional findings.
